A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Exclusion Criteria

• •Subjects with retinal pathology in the study eye other then (NPDR)
• •Subjects with high myopia in the study eye
• •Subjects who have monocular vision or central lateral vision of 20/200 or worse BCVA in the non-study eye.
• •Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less then 6 months prior to study enrollment.
• •Subjects that have either vitrectomy surgery, intavitreal injections, or laser treatments in the study eye.